Aqr Capital Management LLC Immuno Gen, Inc. Transaction History

Aqr Capital Management LLC

$58.2 Billion
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.46 - $29.95 $599,500 - $1.44 Million	-48,114 Reduced 38.3%	77,523 $2.3 Million
Q3 2023 Nov 14, 2023	BUY	$14.09 - $19.87 $1.41 Million - $1.98 Million	99,725 Added 384.86%	125,637 $1.99 Million
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $4,252 - $22,736	1,134 Added 4.58%	25,912 $488,000
Q1 2023 May 15, 2023	SELL	$3.67 - $4.92 $5,130 - $6,878	-1,398 Reduced 5.34%	24,778 $95,000
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $18,887 - $27,277	-4,216 Reduced 13.87%	26,176 $125,000

Q2 2022 Aug 15, 2022	SELL	$3.15 - $5.76 $661,276 - $1.21 Million	-209,929 Reduced 87.35%	30,392 $137,000
Q1 2022 May 16, 2022	BUY	$4.26 - $7.48 $203,470 - $357,267	47,763 Added 24.8%	240,321 $1.14 Million
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $7,699 - $12,157	1,621 Added 0.85%	192,558 $1.43 Million
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $137,628 - $180,671	-27,416 Reduced 12.56%	190,937 $1.08 Million
Q2 2021 Aug 16, 2021	BUY	$5.79 - $8.6 $480,598 - $713,843	83,005 Added 61.33%	218,353 $1.44 Million
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $292,058 - $473,133	44,932 Added 49.69%	135,348 $1.1 Million
Q4 2020 Feb 16, 2021	SELL	$3.7 - $7.66 $540,618 - $1.12 Million	-146,113 Reduced 61.77%	90,416 $583,000
Q3 2020 Nov 16, 2020	SELL	$3.45 - $4.89 $382,208 - $541,738	-110,785 Reduced 31.9%	236,529 $852,000
Q2 2020 Aug 17, 2020	BUY	$3.32 - $5.34 $229,697 - $369,453	69,186 Added 24.88%	347,314 $1.6 Million
Q1 2020 May 15, 2020	BUY	$2.12 - $6.8 $88,785 - $284,784	41,880 Added 17.73%	278,128 $948,000
Q4 2019 Feb 14, 2020	BUY	$2.25 - $5.8 $76,869 - $198,151	34,164 Added 16.91%	236,248 $1.21 Million
Q3 2019 Nov 14, 2019	BUY	$2.22 - $3.39 $302,943 - $462,602	136,461 Added 207.95%	202,084 $489,000
Q2 2019 Aug 14, 2019	SELL	$1.8 - $3.3 $190,837 - $349,869	-106,021 Reduced 61.77%	65,623 $142,000
Q1 2019 May 14, 2019	BUY	$2.41 - $5.91 $244,815 - $600,355	101,583 Added 144.99%	171,644 $465,000
Q4 2018 Feb 14, 2019	SELL	$3.94 - $9.7 $5,874 - $14,462	-1,491 Reduced 2.08%	70,061 $336,000
Q3 2018 Nov 15, 2018	BUY	$8.6 - $11.26 $14,628 - $19,153	1,701 Added 2.44%	71,552 $678,000
Q2 2018 Aug 14, 2018	SELL	$9.52 - $12.15 $111,288 - $142,033	-11,690 Reduced 14.34%	69,851 $680,000
Q1 2018 May 15, 2018	SELL	$6.7 - $12.95 $2.1 Million - $4.06 Million	-313,416 Reduced 79.35%	81,541 $858,000
Q4 2017 Feb 14, 2018	BUY	$5.07 - $7.92 $1.69 Million - $2.64 Million	333,455 Added 542.19%	394,957 $2.53 Million
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $332,110 - $520,921	61,502	61,502 $470,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account